Clinical Trial

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Trial Details
NCT Number NCT07288931
Lead Sponsor Peking Union Medical College Hospital
Conditions Pheochromocytoma/Paraganglioma (PPGL)
Enrollment 40 participants
Start Date 2024-08-06
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-17